Ruben Buendia

Featured in:

Articles

The effect of dapagliflozin on accelerometer-based measures of physical activity in patients with heart failure: an analysis of the DETERMINE trials

Aug 28, 2024 | eprints.gla.ac.uk | De Boer |Anna Maria |John J.V |Ruben Buendia

Docherty, K. F. et al. (2024) The effect of dapagliflozin on accelerometer-based measures of physical activity in patients with heart failure: an analysis of the DETERMINE trials. Circulation: Heart Failure, (Accepted for Publication)Text333665.pdf - Accepted Version Restricted to Repository staff only704kBItem Type:ArticlesAdditional Information:Funding: The DETERMINE trials were sponsored by AstraZeneca.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.